Barbell Medicine Podcast Episode #391: VO2 Max vs. Cardiorespiratory Fitness, GLP-1 Costs, and the 10,000-Step Myth | Direct Line March 2026 (Free)
29 snips
Mar 24, 2026 A rapid AMA covering VO2 max versus broader cardiorespiratory fitness and why single-metric targets can mislead. They unpack current out-of-pocket costs for GLP-1 medications and how manufacturer programs change pricing. They challenge the 10,000-step myth, explore walking intensity versus volume, and offer practical trade-offs between steady walking and higher-intensity cardio.
AI Snips
Chapters
Transcript
Episode notes
VO2 Max Is Useful But Not The Whole Cardiorespiratory Picture
- VO2 max and cardiorespiratory fitness are related but not identical metrics, and many longevity studies use performance-based tests rather than direct VO2 max measurements.
- Jordan Feigenbaum and Austin Baraki note VO2 max is directionally useful but collapsing CRF to one metric risks missing peripheral adaptations and measurement differences.
Chasing One Metric Can Distort Training Choices
- Targeting a single biomarker like VO2 max can encourage narrow protocols that optimize the metric but neglect other valuable training adaptations.
- Austin Baraki warns of Goodhart-like effects where optimizing one number causes people to exclude other effective training methods.
Use Field Benchmarks Not Just VO2 Max
- Monitor cardiorespiratory fitness with practical benchmarks, not just VO2 max, to ensure your exercise actually improves fitness.
- Jordan Feigenbaum recommends field tests and multiple modalities as part of the Barbell Medicine Vital Five benchmarks.